CH EPL (R5)
1.0.0 - trial-use Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Reimbursement SL 21203 1 Pre-Filled Pen

CH - EPL Reimbursement SL

url

FOPHDossierNumber

value: FOPH Dossier Number/21203

url

status

value: Reimbursed

url

statusDate

value: 2021-06-01

url

expiryDate

value: 2100-12-31

url

listingStatus

value: Listed

url

listingPeriod

value: 2021-06-01 --> 2100-12-31

url

firstListingDate

value: 2021-06-01

url

costShare

value: 10

url

productType

value: Originator product

url

gamme

value: Parenteral

value: CHF371.10 (CHF)

type: Ex-factory price

changeType: Normal price mutation

changeDate: 2023-12-01

url

CH - EPL Product Price

value: CHF419.95 (CHF)

type: Retail price

changeType: VAT-change

changeDate: 2023-12-01

url

CH - EPL Product Price

subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-7601001010604-6783101-001; containedItemQuantity = 1 Pre-filled pen; description = ABRILADA Inj Lös 40 mg/0.8ml Fertpen 1 x 0.8 ml

type: Reimbursement SL

Indications

-ExtensionReference
*, , , , , , ClinicalUseDefinition: type = indication

holder: Organization Pfizer AG

Generated Narrative: Organization #holder-Pfizer-AG

identifier: LOC Identifier/100015286, GLN Identifier/7601001010604

name: Pfizer AG